FDA’s de­cen­tral­ized tri­al guid­ance: PhRMA, Mayo Clin­ic and oth­ers seek tweaks

Af­ter the FDA this past spring laid out its ap­proach to de­cen­tral­ized clin­i­cal tri­als, stake­hold­ers are large­ly wel­com­ing the guid­ance, but are ask­ing the agency …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER